The termination of the unused ATM facility removes a potential future dilution risk, which is a modest positive for existing shareholders. However, with no shares ever sold and no financial data in this filing, the primary takeaway is the elimination of an overhang. Monitor for any subsequent capital-raising plans or operational updates, as the company's cash position and funding needs remain undisclosed.
Price Chart
Executive Summary
EUDA Health Holdings filed a 424B5 prospectus supplement to terminate its $10.0 million at-the-market (ATM) offering agreement with Chardan Capital Markets, effective June 5, 2026. No shares were ever sold under the ATM Agreement, removing a potential future dilution overhang. This is a neutral-to-mildly-positive administrative event that eliminates a standing equity issuance facility, but the company's fundamentals remain opaque from this filing alone.
Key Facts
- EUDA terminated its $10.0 million ATM offering agreement with Chardan Capital Markets on June 5, 2026.
- No ordinary shares were ever sold under the ATM Agreement or related prospectus supplements.
- The ATM offering was previously suspended and the maximum aggregate offering price reduced to zero in June 2026.
- EUDA's ordinary shares trade on Nasdaq under symbol 'EUDA'; closing price on July 21, 2026 was $15.30.
- This filing terminates all related prospectus supplements effective July 22, 2026.
Financial Impact
Removal of up to $10.0 million in potential future dilution from an ATM facility that was never utilized. No immediate financial impact.
Risk Factors
- No information on current cash position or operating performance; the company may still need to raise capital through other means.
- The company has a history of multiple shelf/offering filings, indicating potential ongoing capital needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-034161 |
| Document: 0001493152-26-034161-index-headers.html | 0001493152-26-034161 |
| Document: 0001493152-26-034161-index.html | 0001493152-26-034161 |
| Document: 0001493152-26-034161.txt | 0001493152-26-034161 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $17.01 $14.90 | ▲ +12.40% | ▲ +11.25% | $14.46 (+14.99%) |
Oct 13, 2026 13d ago | 6-K | $17.01 $14.90 | ▼ −12.40% | ▼ −11.25% | $14.46 (−14.99%) |
Aug 26, 2026 8w ago | Press Release | $14.10 $13.84 | ▼ −1.84% | ▼ −1.72% | $14.46 (+2.55%) |
Aug 11, 2026 11w ago | EFFECT | $15.23 $14.49 | ▲ +4.87% | ▲ +4.47% | $14.46 (+5.06%) |
Jul 31, 2026 12w ago | 6-K | $19.30 $15.90 | ▼ −17.62% | ▼ −21.13% | $14.46 (−25.08%) |
Jul 22, 2026 13w ago | 424B5 | $14.00 $20.35 | ▲ +45.36% | ▲ +47.76% | $14.46 (+3.29%) |
Jun 11, 2026 19w ago | 424B5 | $15.02 $16.49 | ▲ +9.79% | ▲ +9.35% | $14.46 (−3.73%) |
Apr 28, 2026 25w ago | Press Release | $12.00 $16.31 | ▲ +35.92% | ▲ +34.22% | $14.46 (+20.50%) |
Mar 19, 2026 31w ago | Press Release | $7.98 $11.44 | ▲ +43.36% | ▲ +45.57% | $14.46 (+81.20%) |
Mar 4, 2026 33w ago | Press Release | $15.74 $10.04 | ▼ −36.21% | ▼ −34.88% | $14.46 (−8.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers